NCT07394361

Brief Summary

Systemic lupus erythematosus (SLE) is a chronic, autoimmune, inflammatory disease with the potential to affect any organ in the body. The most frequently affected anatomical regions include the skin, joints, pleura, pericardium, kidneys and the central nervous system. All systemic conditions observed in SLE cause functional deficiencies in daily life, fatigue, anxiety and depression, pain, sleep quality disorders, cognitive effects, cosmetic problems, social isolation, and all these characteristics negatively affect the quality of life of an individual with SLE. The aim of this study is to investigate the effects of clinical pilates exercises on pain, fatigue, functional capacity, flexibility, emotional state, sleep and quality of life in patients with SLE.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Mar 2025Jul 2026

Study Start

First participant enrolled

March 7, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 24, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 6, 2026

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

February 6, 2026

Status Verified

April 1, 2025

Enrollment Period

11 months

First QC Date

April 24, 2025

Last Update Submit

February 3, 2026

Conditions

Keywords

LupusClinical Pilates

Outcome Measures

Primary Outcomes (1)

  • Fatigue status (Fatigue Severity Scale)

    The patient's fatigue status will be evaluated using the fatigue severity scale (FSS). The FSS is a self-administered questionnaire with 9 items (questions) investigating the severity of fatigue in different situations during the past week. Grading of each item ranges from 1 to 7, where 1 indicates strong disagreement and 7 strong agreement, and the final score represents the mean value of the 9 items.

    5 months

Secondary Outcomes (6)

  • Pain score (Visual Analog Scale)

    5 months

  • Emotional state (Hospital Anxiety and Depression Scale)

    5 months

  • Functional capacity (6-minute walking test, 30-second sitting test, Handgrip measurement)

    5 months

  • Sleep quality (Jenkins sleep scale)

    5 months

  • SLE quality of life (Systemic lupus erythematosus quality of life scale)

    5 months

  • +1 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

The intervention group will participate in supervised clinical Pilates exercises. These exercises will be administered in the form of group sessions, which are to be held twice per week. In addition to the home exercise program, which is to be followed for a period of eight weeks.

Other: Clinical Pilates TrainingOther: Home exercise program

Control group

ACTIVE COMPARATOR

The control group will be provided with a home exercise program. This program will consist of stretching, relaxation, and strengthening exercises, to be performed three days a week for a period of eight weeks.

Other: Home exercise program

Interventions

Warm-up (5 min) Segmental extremity movements Centering Roll down Pilates exercises (35 min) One leg stretch Double leg stretch Shoulder bridge Chest lift Hundreds Side band Arm opening Cobra Swimming Push-up Cool-down (5 min) Cat stretching Camel stretching Relaxation exercises

Intervention group

This program will consist of stretching, relaxation, and strengthening exercises, to be performed three days a week for a period of eight weeks.

Control groupIntervention group

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly female participants will be included to the study.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • being a woman between the 18 Years to 65 Years ,
  • meeting the American College of Rheumatology SLE diagnostic criteria,
  • having low disease activity (SLEDAI ≤4),
  • agreeing to participate in the study

You may not qualify if:

  • presence of malignancy, pregnancy, change of treatment within the last 3 months,
  • use of steroids equivalent to \>16 mg prednisolone for the last 3 months, - -
  • have other rheumatic diseases,
  • have a regular exercise habit (physical activity more than two times a week),
  • have a disease that restricts physical activity (such as neurological disorder, orthopedic disorder, cognitive disorder, immobility),
  • have serious heart, lung or kidney involvement,
  • uncontrolled hypertension,
  • severe anemia (hb \<8 g/dL),
  • having undergone orthopedic surgery in the last 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cukurova University

Adana, Saricam, 01250, Turkey (Türkiye)

Location

Related Publications (2)

  • Hashemi, S., Farahbakhsh, S., Fallahi, A., Daryanoosh, F., Babaei Beigi, M. A., & Jamshidian Tehrani, N. (2024). Aerobic and Anaerobic Exercise Benefits for Lupus: Fatigue, Fitness, and Life Quality. Iranian Rehabilitation Journal, 22(3), 499-508.

    BACKGROUND
  • Ismail AMA, Saad AE, Abd-Elrahman NAF, Elfahl AMA. Response of Lipid Profile to Laser Acupuncture along with Diet and Pilates Exercise in Obese Women with Systemic Lupus Erythematosus: a Randomized Controlled Trial. J Acupunct Meridian Stud. 2023 Aug 31;16(4):152-158. doi: 10.51507/j.jams.2023.16.4.152.

MeSH Terms

Conditions

Lupus Erythematosus, Systemic

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Asst. Prof.

Study Record Dates

First Submitted

April 24, 2025

First Posted

February 6, 2026

Study Start

March 7, 2025

Primary Completion

January 30, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

February 6, 2026

Record last verified: 2025-04

Locations